Qvintip

DEVICE2 trials

Sponsors

Marc Arbyn, Universiteit Antwerpen

Conditions

Cervical CancerCervical Intraepithelial Neoplasia Grade 2/3

Unknown Phase

Validation of Human Papillomavirus Assays and Collection Devices for Self-samples and Urine Samples

Active, not recruitingNCT03064087

Marc ArbynCervical Intraepithelial Neoplasia Grade 2/3

Start: 2017-12-29End: 2027-11-17Updated: 2023-03-29

First-void Urine Samples for the Follow-up of Women Treated for High-grade Cervical Intraepithelial Neoplasia (CIN)

CompletedNCT03542513

Universiteit AntwerpenCervical Cancer

Start: 2017-10-30End: 2024-09-25Updated: 2025-06-13

Related Papers

Equivalent Clinical Accuracy of Human Papillomavirus DNA Testing Using Cobas 4800 and 6800 Human Papillomavirus Systems in Paired Urine and Cervical Samples.

2025-03-182 citations

Clinical Performance of the RealTi<i>m</i>e High Risk HPV Assay on Self-Collected Vaginal Samples within the VALHUDES Framework.

2022-09-0117 citations

Analytical and clinical performance of extended HPV genotyping with BD Onclarity HPV Assay in home-collected first-void urine: A diagnostic test accuracy study.

2022-08-2439 citations

Cervical cancer screening using HPV tests on self-samples: attitudes and preferences of women participating in the VALHUDES study

Archives of Public Health2021-08-3064 citations

Clinical and analytical evaluation of the RealTime High Risk HPV assay in Colli-Pee collected first-void urine using the VALHUDES protocol.

2021-06-2354 citations